Skip to main content
Premium Trial:

Request an Annual Quote

Third Wave Sees Revenues Dwindle, Profits Turn to Losses in Q1; Downturn Termed Temporary

NEW YORK, May 5 (GenomeWeb News) - Third Wave Technologies today reported a sharp downturn in revenues and a net loss for the first quarter of 2005.


Revenues for the period totaled $7.1 million, down from $15.3 million during the same quarter in 2004. Third wave attributed this shortfall to a lack of research revenue, a delay by one of its suppliers, and "performance issues" with an instrument from Roche that is required for Third Wave's HCV genotyping analyte-specific reagents.


"As expected, our research revenue will continue to be lower than it has been historically," CEO John Puisis said in a company statement. "We believe the temporary delays that impacted our molecular diagnostic revenue in the first quarter have been remedied."


Research and development costs stayed flat at $2.5 million compared to $2.7 million during last year's first quarter.


Third Wave recorded a net loss of $4.4 million, or $.11 per share, compared to net earnings of $2.8 million, or $.07 per share, during the same quarter last year.


As of March 31, Third Wave had $64.5 million in cash, cash equivalents, and short-term investments.

The Scan

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.

Team Presents Cattle Genotype-Tissue Expression Atlas

Using RNA sequences representing thousands of cattle samples, researchers looked at relationships between cattle genotype and tissue expression in Nature Genetics.

Researchers Map Recombination in Khoe-San Population

With whole-genome sequences for dozens of individuals from the Nama population, researchers saw in Genome Biology fine-scale recombination patterns that clustered outside of other populations.

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.